Ilika reaches key production milestone for Stereax micro-batteries
By Josh White
Date: Monday 18 Aug 2025
(Sharecast News) - Ilika said Monday that it has reached a key production milestone for its Stereax micro-batteries, following the successful qualification of the manufacturing process at its partner Cirtec Medical's facility in Massachusetts.
The AIM-traded firm said the milestone, which came after commissioning equipment earlier in the year, marked the final technical validation step before full-scale production.
It said the line incorporated advanced deposition, alignment and patterning systems required for medical-grade micro-battery manufacturing.
Production had now started to support product testing and initial customer deliveries.
The achievement triggered a 10-year manufacturing agreement signed in 2023 under which Cirtec would produce Ilika's Stereax battery portfolio.
"This manufacturing milestone demonstrates the successful technology transfer of our proprietary Stereax platform to commercial production scale," said chief executive Graeme Purdy.
"The strong customer interest we're seeing validates the market need for miniaturised solid-state batteries in medical devices.
"With the combination of Ilika's expertise and Cirtec Medical's world-class manufacturing capabilities, we are well-positioned to meet growing customer demand in 2025 and beyond."Ilika said the collaboration aimed to meet rising demand for miniaturised power solutions in implantable medical devices by combining its solid-state battery technology with Cirtec's established expertise in medical device production.
Initial deliveries of the Stereax M300 were targeted to start later in 2025.
"The successful qualification of Stereax battery production strengthens our position as a leading manufacturer of next-generation medical devices," commented Ed Philbin, interim chief executive of Cirtec Medical.
"By incorporating Ilika's innovative micro-battery technology into our vertically integrated manufacturing capabilities, we can offer our customers unprecedented opportunities for device miniaturisation and enhanced performance in implantable medical applications."
At 1222 BST, shares in Ilika were up 5.02% at 44.95p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN